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Abstract
Background: Macrophage migration inhibitory factor (MIF) is essential for controlling parasite burden and survival in a
model of systemic Toxoplasma gondii infection. Peroral T. gondii infection induces small intestine necrosis and death in
susceptible hosts, and in many aspects resembles inflammatory bowel disease (IBD). Considering the critical role of MIF in
the pathogenesis of IBD, we hypothesized that MIF participates in the inflammatory response induced by oral infection with
T. gondii.
Methodology/Principal Findings: Mif deficient (Mif
2/
2) and wild-type mice in the C57Bl/6 background were orally infected
with T. gondii strain ME49. Mif
2/
2 mice had reduced lethality, ileal inflammation and tissue damage despite of an increased
intestinal parasite load compared to wt mice. Lack of MIF caused a reduction of TNF-a, IL-12, IFN-c and IL-23 and an
increased expression of IL-22 in ileal mucosa. Moreover, suppressed pro-inflammatory responses at the ileal mucosa
observed in Mif
2/
2 mice was not due to upregulation of IL-4, IL-10 or TGF-b. MIF also affected the expression of matrix
metalloproteinase-9 (MMP-9) but not MMP-2 in the intestine of infected mice. Signs of systemic inflammation including the
increased concentrations of inflammatory cytokines in the plasma and liver damage were less pronounced in Mif
2/
2 mice
compared to wild-type mice.
Conclusion/Significance: In conclusion, our data suggested that in susceptible hosts MIF controls T. gondii infection with
the cost of increasing local and systemic inflammation, tissue damage and death.
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Introduction
The immune/inflammatory response to Toxoplasma gondii
infection is essential to control parasite replication and tissue
spread but also can cause tissue damage, being descisive to
pathogenesis. Selective tissue invasion by T. gondii causes
compartmental immune responses unique to each tissue such as
the one present in the placenta, central nervous system and
intestinal mucosa, while parasite spreading promotes a systemic
response that resembles bacterial sepsis [1–3]. Inhibition or
abrogation of TNF-a, IL-12 and/or IFN-c increase host
susceptibility to toxoplasmosis as a result of uncontrolled parasite
burden [4–6]. In natural T. gondii infection through the oral route,
exacerbated inflammatory responses at the small intestine (ileitis)
resemble human inflammatory bowel disease (IBD) [1,7].The
inflammatory response coordinate by IL-23/IL-22 is involved in
T. gondii-induced disruption of intestinal homeostasis and immu-
nopathology, an effect at least in part due to increase expression of
matrix metalloproteinase-2 (MMP) [7]. These pro-inflammatory
mediators and MMPs are involved in the immune pathogenesis
and tissue damage in T. gondii peoral infection, increasing host
morbidity and mortality despite parasite control [7–9]. Deficient
regulation of the inflammatory response observed in the absence of
IL-10 results in massive leukocyte infiltration, extensive tissue
damage despite control of parasite load, systemic inflammation
and increase lethality [2].
MIF is a versatile molecule that comprises hormonal and
enzymatic activities in addition to exert pro-inflammatory and
chemotactic functions [10–13]. First described as a T-cell-derived
factor involved in the inhibition of macrophage migration in
delayed–type hypersensitivity response, MIF is also produced by
other immune cells such as macrophages, neutrophils and
eosinophils but also non immune cells such as endothelial,
epithelial, muscle and pituitary cells [10–15]. MIF expression
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which results in counter-regulation of cortisol [11,16]. MIF
production is also regulated by TNF and LPS-Toll-like receptor
4 (TLR4) in a positive feedback cascade resulting in enhanced
proinflammatory responses [15,17,18]. Furthermore, MIF is an
essential regulator of innate and adaptive immune responses with a
crucial role in host protection against different pathogens and is
involved in the pathogenesis of a broad spectrum of infectious and
non infectious inflammatory diseases [10–23].
In parasitic infections MIF is involved both in protective as well
as immune pathogenic responses [12,21,24–28]. Upon systemic
infection with T. gondii, IFN-c and TNF-a mediated responses are
upregulated by MIF, and Mif
2/
2 mice are more susceptible to
infection presenting increased parasite burden [27]. A recent study
also demonstrated an increased susceptibility, reduced IL-12
production and dendritic cell activation on Mif
2/
2 mice in the
Balb/c background to an oral T. gondii infection [28]. Balb/c mice
are naturally resistant to oral infection with T. gondii, while
C57BL/6 are highly susceptible and display intestinal inflamma-
tion, especially in the ileum [29–31].
Considering the role of MIF on intestinal inflammation, we
hypothesize that MIF participates in the pathogenesis of T. gondii-
induced intestinal tissue damage. Our results indicate that MIF
mediates pathogenic responses during T. gondii oral infection by
exacerbating compartmental and systemic inflammatory respons-
es. The lack of MIF caused an overall reduction of tissue damage
despite of an increase in local parasite burden.
Materials and Methods
Mice
C57BL/6 (wild type, wt) and Mif
2/
2 (backcrossed to the
C57BL/6 genetic background, n=8) were obtained from the
animal facility at the Universidade Federal do Rio de Janeiro
(UFRJ, Rio de Janeiro). Sex and age-matched (8–12 week-old)
C57BL/6 were used as controls for Mif
2/
2. The animals were
kept at constant temperature (25uC) with free access to chow and
water in a room with a 12 h light/dark cycle. All animal
experiments were performed in accordance to Brazilian Govern-
ment’s ethical and animal experiment regulations. The experi-
ments were approved by the Institutional Animal Welfare
Committee (approval ID: CEUA/CCS/UFRJ/IMPPG 011).
Parasites and per oral infection
The T. gondii strain ME49 was kindly provided by Dr R.
Gazzinelli, (UFMG, Minas Gerais, Brazil) and Dr J. Lannes-Vieira
(FIOCRUZ, Rio de Janeiro, Brazil). For peroral infection, mice
were infected by gavage using 20 and 100 ME49 cysts/animal.
Cysts were obtained from C57BL/6 brain homogenates as
previously described [2].
Detection of T. gondii DNA
Parasites in tissues were quantified by a real-time polymerase
chain reaction (RT-PCR) as previously described [7] targeting a
repetitive 529-bp DNA fragment of T. gondii (GenBank accession
no AF487550) [32] which are specific for a cryptic gene as
described [33]. Fifty to 100 mg of ileum and liver tissues were
crushed in a rotor-stator after frozen in liquid nitrogen and total
DNA were isolated with DNAzol reagent (Invitogen Life
Technologies) following the manufactures protocol. Five hundred
ng of total DNA extracted from each sample were submitted to
real-time PCR using Power SYBRH Green PCR master mix
(Applied Biosystems) using each oligonucleotide primer (TOX-9,
59-AGGAGAGATATCAGGACTGTAG-39; TOX-10, 59-
GCGTCGTCTCGTCTAGATCG-39). The amplification was
performed using one cycle at 95uC for 10 min, 45 cycles at
95uC for 30 s, 60uC for 1 min. A standard curve was performed
using 5000-5 pg T. gondii DNA to quantification of total DNA of
samples.
Determination of small intestinal length, histopathology
and histological scores
Small intestinal shortening was determined by measuring whole
intestinal segment of wt and Mif
2/
2 controls and T. gondii-infected
mice. It was calculated by dividing the difference of the mean
length of the small intestine from control mice minus the length
from infected mice at day 8 after infection and then multiplied by
100 over the mean length of mice small intestines [34]. Intestines,
liver and brain were fixed in 10% neutral buffered formalin,
embedded in paraffin, sectioned at 5 mm, and stained with
hematoxylin and eosin using standard techniques. Blinded samples
were submitted for semi-quantitative histopathologic analysis.
Histological scores were determined in fixed and paraffin-
embedded tissue sections taken from the terminal ileum, as
previously described [34]. Liver sections were analyzed for the
numbers of inflammatory foci at a magnification of6200 at day 9
after infection in each group. We analyzed the number of
inflammatory foci per field (6.569 mm, microscope Zeiss,
Germany) counting 10 fields of each section.
Determination of cytokine concentrations at the
intestinal tissue and plasma
Plasma samples were obtained to measure cytokine concentra-
tions. IFN-c and TNF-a concentrations were measured by a
commercial ELISA from Peprotech (NJ, USA). Concentrations of
IL-10 was determined by ELISA using a commercial kit from
R&D Systems (MN, USA).
RT-PCR analysis of matrix metalloproteinases and
cytokines
Approximately 50–100 mg of ileum tissue were crushed in a rotor–
stator after frozen in liquid nitrogen and total RNA were isolated with
TRIzol reagent (Invitogen Life Technologies) following the manufac-
tures protocol. Four micrograms of total RNA extracted were reverse
transcribed using a High capacity cDNA reverse transcription kit
(Applied Biosystems, Foster City, CA). Each sample was submitted to
real-time PCR using Power SYBRH Green PCR master mix (Applied
Biosystems). The reactions were carried out using specific primers for
the following genes: MMP-2 (forward, 59-CAATCTTTTCTGG-
GAGCTC-39; reverse, 59-GCTGATACTGACACTGGTACTG-
39), MMP-9 (forward, 59-CCTGGAACTCACACGACATCTTC-
39; reverse, 59-TGGAAACTCACACGCCAGAA-39), TNF-a (for-
ward, 59-CCTCACACTCAGATCATCTTCTCA-39; reverse, 59-
TGGTTGTCTTTGAGATCCATGC-39), IL-6 (forward, 59-T C A -
TATCTTCAACCAAGAGGTA-39; reverse, 59- CAGTGAGGA-
ATGTCCACAAACTG-39), IFN-c (forward, 59-AGCAACAGCA-
AGGCGAAAA-39; reverse, 59- CTGGACCTGTGGGTTGTTGA
-39), IL-17A (forward, 59-TCCCTCTGTGATCTGGGAAG-39;
reverse, 59-CTCGACCCTGAAAGTGAAGG-39), TGF-b (forward,
59-GACCGCAACAACGCCATCTA-39; reverse, 59-AGCCCTG-
TATTCCGTCTCCTT-39), IL-12p35 (forward, 59-CCACCCTT-
GCCCTCCTAAAC-39;r e v e r s e ,5 9-GGCAGCTCCCTCTTGTT-
GTG-39), IL-23 (forward, 59-TGGCATCGAGAAACTGTGAGA-
39; reverse, 59-TCAGTTCGTATTGGTAGTCCTGTTA-39), IL-
22 (forward, 59-GACAGGTTCCAGCCCTACAT-39; reverse, 59-
GTCGTCACCGCTGATGTG-39), IL-10 (forward, 59-TAAGG-
GTTACTTGGGTTGCCAAG-39; reverse, 59-CAAATGCTCCT-
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amplification cycles consisting in 95uC for 30 s, 60uCf o r1m i n .
The expression of the hypoxanthine guanine phosphoribosyl
transferase 1 (Hprt1) gene (forward, 59-GCTGGTGAAAAG-
GACCTCT-39; reverse 59-CAC AGG ACT AGA ACA CCT GC-
39) was used to normalize the results, which were presented as fold
induction of mRNA expression relative to control samples. Moreover,
mouse TaqMan pre-developed assay reagents (Applied Biosystems)
were used for IL-4 and Hprt amplification. The analyses of relative
gene expression data were performed by 2
2DDC
T method [35].
Statistical analysis
Data are expressed as means 6 SEM. The statistical
significance of differences in mean values was determined by
using Student’s t test or ANOVA. Survival data are presented as a
Kaplan-Meier survival curve and analyzed with Log-rank test by
software Prism 5 (USA). Differences of at least p#0.05 are
considered significant.
Results
Reduced mortality and morbidity of Mif
2/2 mice after
T. gondii oral infection
It has been recently demonstrated that MIF determines host
susceptibility to T. gondii infection by peritoneal route [27]. Mif
2/
2
mice presente increased parasite load and systemic inflammatory
response when compared to wt mice. However, T. gondii infection
through the oral route might determine a different outcome
depending on the inflammatory response within the intestinal
mucosa [36,37]. To define the role of MIF during natural T. gondii
infection in susceptible hosts, wt and Mif
2/
2 mice were orally
infected with 100 or 20 cysts per animal. Wt mice infected with 100
cysts were all dead after 10–12 days post infection while Mif
2/
2 mice
hada significant increase of survival (Fig. 1A).Theincrease survivalof
Mif
2/
2 compared to wt mice was even more pronounced upon
infection with 20 cysts/animal (Fig. 1B). To assess morbidity during
acute T. gondii infection, we used weight loss and hematocrit
measurement, considered good markers of morbidity in acute
acquired toxoplasmosis [38]. Although both wt and Mif
2/
2 mice
presented weight loss, it was more severe in wt than on Mif
2/
2 mice
(Fig. 1C). Similarly, hematocrit was significantly reduced in infected
wt when compared to Mif
2/
2 mice (Fig. 1D). Thus, Mif
2/
2 mice
displayed increased resistance to acute infection and reduced
morbidity following per oral T. gondii infection.
Reduced ileal damage despite of increased parasite loads
in the absence of MIF
To determine the cause of reduced mortality of Mif
2/
2 mice,
we initially performed macroscopical and histopathological
analysis of the small intestine of control and infected animals. At
day 9 post infection, wt mice presented significant intestinal
shortening compared to Mif
2/
2 mice (Fig. 2A). This intestinal
shrinkage observed in wt mice was associated with histological
changes at the terminal ileum, including blunting of the villi,
extensive necrosis and full thickness inflammatory infiltration of
the lamina propria (Fig. 2B). Infected Mif
2/
2 mice presented
reduced necrosis and decreased loss of mucosal integrity, lamina
propria and intestinal wall and more preserved areas of intestine.
Tissue damage was determined by histopathological scores of the
terminal ileum of infected mice, and most samples from wt mice
Figure 1. MIF increases morbidity and mortality during peroral T. gondii infection. Survival curves of Mif
2/
2 (C57BL/6) mice (6–8 weeks
old) and age and sex-matched wild type controls orally infected with 100 (A) and 20 cysts (B) of ME-49 strain of T. gondii. Morbidity was evaluated by
determining animal (C) relative weight loss and (D) hematocrit. One representative experiment out of three performed. Data from 8 to 10 animals per
group are given as mean 6 SEM, and p values were determined by t-test (* p#0.05) or by Log-rank test (A, B). Cont, control not infected.
doi:10.1371/journal.pone.0025259.g001
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2/
2 mice (Fig. 2C).
In fact, Mif
2/
2 mice displayed less tissue damage in contrast to a
significant increase in tissue parasitism (Fig. 2D). These findings
indicate that MIF-mediated inflammatory response promotes
tissue damage, contributing to morbidity and mortality, but also
participates on T. gondii control at the intestinal mucosa.
MIF regulates inflammatory cytokines in T. gondii-
induced ileitis
To investigate the mechanism by which MIF regulates the
inflammatory response at the intestinal mucosa, we examined
mRNA expression and the concentrations of inflammatory
cytokines in the supernatants of ileal mucosal explants from wt
and Mif
2/
2 infected mice. TNF-a, IL-12, IFN-c and IL-23
expression were decreased in infected Mif
2/
2 mice when
compared to wt mice (Fig. 3A–C, E). The mRNA expression of
IL-6 and IL-17A were also similar in wt and Mif
2/
2 mice (Fig. 3D,
F). Surprisingly, IL-22 expression was significantly increased in
infected Mif
2/
2 compared to wt mice (Fig. 3G). To determine if
IL-4, IL-10 and TGF-b could be implicated in the suppression of
immunopathology and increased parasite burdens of Mif
2/
2,w e
examined the mRNA expression of these regulatory cytokines in
the ileal mucosa explants of control and infected wt and Mif
2/
2
mice. While IL-4 mRNA expression was similar in wt and Mif
2/
2
mice at 9 days post infection (Fig. 4A), IL-10 mRNA expression
and protein in ileal mucosa were reduced in Mif
2/
2 compared to
wt mice (Fig. 4B, data not shown). Similarly, T. gondii infected
Mif
2/
2 mice presented significant decrease of TGF-b expression
when compared to infected wt mice (Fig. 4C). These results
indicate that the reduced inflammatory response in the ileun of
Mif
2/
2 compared to wt mice is not due to up regulation of IL-4,
IL-10 or TGF-b.
T. gondii peroral infection induces decreased expression
of MMP-9, but not MMP2, in the intestinal mucosa of
Mif
2/
2 mice
Matrix metalloproteinases have been implicated in the patho-
genesis of IBD and most recently in T. gondii-induced ileitis [7].
Given that MIF regulates the expression of MMPs during
pathological inflammatory responses such as arthritis [39,40], we
investigated the possible involvement of MMP-2 and MMP-9 in T.
gondii-induced MIF-mediated ileitis. We determined the mRNA
expression of MMP-2 and MMP-9 in the ileum of control and
infected wt and Mif
2/
2 mice. At day 9 post-infection, both control
and infected wt and Mif
2/
2 mice presented similar MMP-2
expression (Fig. 5A). However, MMP-9 was significantly reduced
in the ileum of Mif
2/
2 infected mice (Fig. 5B). These results
suggest that MIF might contribute to pathological responses to T.
gondii infection at the intestinal compartment via MMP-9 pathway.
Systemic inflammatory responses are regulated by MIF
and enhance T. gondii-induced pathology
The systemic inflammation during T. gondii infection resembles
bacterial sepsis. Considering the critical role of MIF in the
pathogenesis of experimental sepsis, we investigated several
markers of systemic inflammation in T. gondii-infected wt and
Mif
2/
2 mice. Leukocyte counts were higher in wt mice at day 4
and 7 post-infection when compared to Mif
2/
2 mice (Fig. 6A).
Given that systemic inflammation during per oral infection are
induced by pro-inflammatory mediators such as IFN-c and TNF-
a, we investigated the concentrations of these cytokines in the
plasma of infected wt and Mif
2/
2 mice. The concentrations of
both cytikones were higher in wt compared to Mif
2/
2 mice
(Fig. 6B, C). Thrombosis was often associated with vascular
inflammatory infiltration in the livers of wt and Mif
2/
2 mice
(Fig. 6D). Wt mice had increased numbers of mononuclear cell
infiltrates in perivascular areas and scattered at the hepatic
parenquima (Fig. 6D, E). In contrast, infected Mif
2/
2 mice had
preserved liver parenquima and reduced mononuclear cell
infiltration (Fig. 6D, E). Wt mice presented higher alanine
aminotransferase and aspartate aminotransferase plasma concen-
trations compared to Mif
2/
2 mice, an indication of liver damage
and dysfunction (Fig. 6F, G). Moreover, T. gondii DNA levels were
similar in wt and Mif
2/
2 mice (Fig. 6H). The findings suggest that
Figure 2. T. gondii-induced ileitis is mediated by MIF that
induces severe tissue damage despite efficient parasite
control. (A) Shortening of small intestine of wt and Mif
2/
2 mice
(n=6) at 9 days post-infection (dpi). (B) Histopathologycal analysis by
hematoxilin and eosin (HE) of terminal ileum was performed at 9 dpi in
wt and Mif
2/
2. Magnification are 6200 (B1, 2, 5 and 6) and 6400 (B3
and 4). In (C) Histologycal scores of ileal biopsies of wt and Mif
2/
2 mice
at 9 dpi. The horizontal line limits absence of inflammatory response (0
to 3) and necrosis (above 3). (D) Toxo DNA concentration was
determined in ileal biopsies of wt and Mif
2/
2 mice. One representative
experiment out of three independent experiments. Data from 3 to 6
mice per group is represented by means 6 SEM and p values
determined by t-test (* p#0.05, ** p#0.01). Length of intestinal
segments of control not infected wt and Mif
2/
2 mice are represented
by a dotted line in A. Cont, control not infected.
doi:10.1371/journal.pone.0025259.g002
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while parasite replication and dissemination is not affected by
MIF.
Discussion
In the present study we demonstrated that MIF increases the
inflammatory response and tissue damage due to T. gondii oral
infection in susceptible C57BL/6 mice. Mif
2/
2 mice had reduced
intestinal and systemic inflammation surviving more compared to
wt mice, despite of an increase in intestinal parasite burden. This
reduced inflammatory response in the intestine of Mif
2/
2 mice
was associated with decreased expression of inflammatory
cytokines and MMP-9 comapared to wt mice. Despite of the lower
expression of IL-23 compared to wt mice in ileal explants, IL-22
expression was siginificantly increased in Mif
2/
2 mice. The
originally local inflammatory response in the small intestine of T.
gondii-infected wt mice had systemic repercussions similar to sepsis,
including increased plasma concentrations of inflammatory
cytokines, leukocytosis and liver damage, all less pronounced in
Mif
2/
2 mice. Together, these results indicate that MIF is involved
in the response to T. gondii infection of the small intestine,
increasing the ileitis and the systemic inflammatory response.
The peroral infection with T. gondii caused a severe ileitis
characterized by intestinal shortening, extensive necrosis, blunting
of the villi, loss of Peyer’s patches and leukocyte infiltration in the
Figure 3. MIF upregulates proinflammatory responses in toxoplasmic ileitis. Real-time PCR of (A) TNF-a, (B) IL-12, (C) IFN-c, (D) IL-6, (E) IL-
23, (F) IL-17 and (G) IL-22 expression in ileal explants from control and infected wt and Mif
2/
2 mice. Results are expressed as fold changes relative to
HPRT mRNA expression. Data from 3 to 6 mice per group is represented by means 6 SEM and p values determined by t-test (* p#0.05, ** p#0.01).
Cont, control not infected.
doi:10.1371/journal.pone.0025259.g003
Figure 4. Reduced intestinal expression of IL-10 and TGF-b in Mif
2/2 mice. Quantitative RT-PCR of of (A) IL-4, (B) IL-10 and (C) TGF-b mRNA
expression in ileal explants of control and infected wt and Mif
2/
2 mice. Results are expressed as fold changes relative to HPRT mRNA expression. Data
from 3 to 6 mice per group is represented by means 6 SEM and p values determined by t-test (*p#0.05). Cont, control not infected.
doi:10.1371/journal.pone.0025259.g004
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significantly reduced on Mif
2/
2 compared to wt mice. In natural
T. gondii infection, gut-associated inflammatory response resembles
that observed in Crohn’s ileitis and it has been proposed as a
model of IBD [1,7,41]. An essential role of MIF in experimental
colonic inflammation has been demonstrated [20]. It has been also
shown that MIF controls the production of inflammatory cytokines
including TNF-a and IFN-c involved in the pathogenesis of
intestinal inflammation [42] In the present study, using a model of
T. gondii-induced ileal inflammation, we demonstrated a critical
role of MIF promoting the intestinal inflammatory response and
the expression of TNF-a, IL-12 and IFN-c.
A recent study showed that during peoral T. gondii infection IL-
23 regulates the ileal inflammatory response independent of IL-17
[7]. We also observed that upon T. gondii infection IL-23
expression was upregulated in the intestine while IL-17 was
reduced. The inflammatory role of IL-23 was dependent of
increased IL-22 production that in turn promoted the ileal
inflammation and tissue damage [7]. IL-22, a member of the IL-
10 family, is important in epithelial cell homeostasis, in infection
and inflammation [43]. In toxoplasmic ileitis, the inflammatory
response is a result of IL-22 upregulation induced by IL-23 [7]. In
fact, T. gondii-infected IL-22
2/
2 mice have reduced intestinal
inflammation and are more resistant than wt. Unexpectaly, we
observed a significant increased of IL-22 expression in Mif
2/
2
mice with reduction of IL-23 and TGF-b. Others have previously
shown increased IL-22 production by T CD4+ lymphocytes in the
absence of IL-23 [44,45]. Thus our results suggest a previously
unrecognized role of MIF inducing IL-23 and inhibiting IL-22
expression. Our results also implies a MIF-dependent pathogenic
role of IL-22 in T. gondii-induced ileitis. Interestingly, an anti-
Figure 5. MIF upregulates MMP-9 but not MMP-2 in the
terminal ileum of T. gondii infected mice. Quantitative real-time
PCR of (A) MMP-2 and (B) MMP-9 mRNAs in ileal biopsies of control and
infected (9 dpi) wt and Mif
2/
2 mice. Results are expressed as fold
changes to HPRT mRNA expression. One representative experiment out
of two experiments is shown. Data of three to five mice per group are
given as means 6 SEM and p values were determined by Mann-
Whitney (**p#0.01). Cont, control not infected.
doi:10.1371/journal.pone.0025259.g005
Figure 6. T. gondii-induced sepsis-like response is partially dependent of MIF. (A) Leukocyte counts were determined in peripheral blood at
indicated times. (B) TNF-a and (C) IFN-c concetrations in the plasma of wt and Mif
2/
2 mice (n=3–5) 9 dpi were measured by ELISA. (D)
Histopathologycal analysis of the liver at 9 dpi from wt and Mif
2/
2 mice. (E) Quantitative analysis of liver sections (3 slides/animal) of infected wt and
Mif
2/
2 mice mice was performed. Liver damage was also determined by quantifying serum concentrations of biochemical marker as (F) alanine
aminotransferase (ALT), and (G) aspartate aminotransferase (AST). (H) Toxo DNA concentration was determined in the liver of wt and Mif
2/
2 mice.
One representative experiment out of six experiments is shown. Data of three to five mice/group are given as as means 6 SEM and p values were
determined by t-test (* p#0.05, ** p#0.01). Cont, control not infected.
doi:10.1371/journal.pone.0025259.g006
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previously demonstrated [46]. Future studies will be importat to
define the mechanism by which MIF controls IL-23 and IL-22
expression, and how MIF participates in the pathogenic role of IL-
22 on T. gondii-induced intestinal inflammation.
We observed that MIF was essential to T. gondii-induced
expression of MMP-9, suggesting that MIF could be involved in
tissue remodeling/repair at the small intestine during T. gondii
peroral infection by over expressing gelatinase B. Several studies
haveshown that MIFaffectstissueremodelingand the expression of
different metalloproteinases [40]. Previous studies demonstrated an
increased expression and enzymatic activity of metalloproteinasesin
humans and mice with intestinal inflammation [7,47]. MMP-2 and
MMP-9 are elevated in the intestine of T. gondii-infected animals,
however in these model, C57BL/6 mice lacking MMP-2 but not
MMP-9 have reduced immunopathology of the small intestine [7].
Thus the exact role of the reduced expression of MMP-9 observed
on Mif
2/
2 upon T. gondii infection requires further investigations.
During intestinal parasitic infection, reduced anti-inflammatory
responses could decrease parasite burden but intensify tissue
damage, causing loss of epithelial barrier integrity and increased
bacterial translocation [34]. Our results showed that MIF mediated
T. gondii-induced ileitis does not affect IL-4 and increase IL-10 and
TGF-b expression. The intestinal inflammatory response induced
by T. gondiiis complex and intestinal homeostasis requires reciprocal
control of both Th1 and TGF-b mediated responses. Consequently,
MIF exacerbation of intestinal inflammatory responses might
involve not only increased pro-inflammatory responses but also
TGF-b-mediated responses. MIF and TGF-b are involved in
fibrotic responses in several conditions due to regulation of MMPs
[48,49]. Since both cytokines upregulate MMP-9 expression, it is
possible that MIF regulates tissue remodeling in T. gondii-induced
ileitis through a TGF-b/MMP-9 pathway.
The reduced inflammatory response and pathological damage
in the small intestine of Mif
2/
2 occurred in the context of higher
T. gondii burden. It has been recently shown in a model of
toxoplasmosis induced by intraperitoneal route that MIF is
essentially protective [27]. In this model of systemic infection,
Mif
2/
2 had higher numbers of cysts in the brain. The increased
susceptibility of Mif
2/
2 mice systemically infected was related
with reduced production of inflammatory cytokines, however these
animals, in opposition to our findings, developed increased liver
damage compared to wt mice [27]. Mif
2/
2 mice of the Balb/c
background are also more susceptible to T. gondii when infected by
the oral route, presenting increased lethality and parasite burden
in the brain and liver [28]. Compared to susceptible hosts such as
C57BL/6, the infection of Balb/c mice with T. gondii by the oral
route causes a less severe intestinal inflammatory response and a
disease that tends to become chronic. These findings suggest that
MIF-mediated T. gondii-induced pathological responses might be
differently regulated depending on the route and site of infection,
and the genetic background of the host.
We observed that Mif
2/
2 mice had reduced signs of systemic
inflammation compared to wt mice when infected by the oral
route. The reduced systemic inflammation of Mif
2/
2 mice was
characterized by lower plasma concentrations of TNF-a and IFN-
c, reduced biochemical and histological parameters of liver
damage and lower leukocytosis when compared to wt mice.
Considering the pathogenic roles of TNF-a and IFN-c in T. gondii
oral infection, we postulate that enhancement of systemic
inflammatory response is mediated by MIF acting in concert with
TNF-a and IFN-c [2,4,5]. A deleterious role of MIF was recently
observed in a mouse model of lethal dengue virus infection, with
reduced systemic inflammatory response in Mif
2/
2 mice compare
to wt mice [50]. Although the molecular mechanisms involved in
toxoplasmic ileitis are not completely understood, new evidence
indicates that co-factors such as Gram-negative intestinal micro-
flora play a role in T. gondii-induced acute ileitis and systemic
inflammation through LPS-induced TLR-4 signaling [51]. Since
MIF up-regulates the expression of TLR-4 [17], it is possible that
the reduced inflammatory response observed in Mif
2/
2 mice
upon T. gondii might be a result of reduced TLR-4 activation.
Considering that MIF contributes to IBD even in the absence of
TLR-4, it is possible that the effect of MIF on T. gondii
pathogenesis occurs independently of its effects on TLR-4
expression. Interestingly, MIF also regulates the expression of
TLR-11 [28], considered important in the recognition and
response to T. gondii [52]. It has been suggest that the reduced
expression of TLR-11 in the absence of MIF affects the
maturation and activation of dendritic cells consequently ham-
pering a protective immune response to T. gondii [28]. It will be
important to characterize the role of TLR-4 and TLR-11 in the
MIF-dependent small bowel injury caused by T. gondii in
susceptible hosts.
In conclusion, we demonstrated that MIF participates in the
pathogenesis of natural T. gondii infection in C57BL/6 mice,
promoting an intense ileitis and a robust systemic inflammatory
response that resulted in poor outcome during the acute phase.
Similar to previous studies, we confirmed a central role of MIF in
the control of parasite burden in different models of experimental
toxoplasmosis [27,28]. Although MIF has been regarded as
essential in host protection during T. gondii infection, our findings
demonstrated a pathogenic role of MIF in natural T. gondii
infection in susceptible hosts by exacerbating IL-12, IFN-c, TNF-a
and IL-23 dependent responses. MIF also plays a role in tissue
remodeling possibly by regulating TGF-b induced MMP-9. Thus,
we propose that MIF actually exerts a bidirectional role in
toxoplasmosis. This dichotomy is dependent on the route of
infection and the genetic background of the host, and has been
also observed with other pro-inflammatory cytokines [2]. In this
scenario, MIF seems to compromise host protection by exacer-
bating intestinal tissue damage and by inducing a sepsis-like
response. Previous studies demonstrating a participation of MIF
on human T. gondii infection [27,53,54] enphasize the importance
to understand the diffrential role of MIF on immunity and
pathogenesis triggered by T. gondii in distinct tissues.
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